Skip to main content
Premium Trial:

Request an Annual Quote

What If I Already Spent That $2,500 On New Lab Equipment?

A Wall Street Journal article looks at the pros and cons of direct-to-consumer genetic tests, such as Health Compass, a test offered by San Francisco Bay Area-based Navigenics and available early next year. Despite the fact that these tests can help predict disease susceptibility, some criticisms of include skepticism about their scientific accuracy, high prices (Navigenics is charging $2,500 for their test), insurance, and privacy issues. "Besides questions about accuracy, there is also the issue of how useful the answers will be," writes the WSJ. "There’s no evidence, many physicians say, that people will act on such information to lead healthier lives."

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.